Fact based stock research
Bio-Rad Laboratories (NYSE:BIO)

US0905722072

Bio-Rad Laboratories stock research in summary

Bio-Rad Laboratories shares have a market-typical stock price level. They are safely financed and are good value, but show below average growth. We recommend evaluating whether the future of the company Bio-Rad Laboratories is typical for this industry which the market average price level of the shares suggests. If you believe that the future of the company is above average, that could be an argument for buying the shares and vice versa.

Latest Obermatt Ranks


Value Rank	56
Growth Rank	44
Safety Rank	78
Combined Rank	67

Country	USA
Industry	Life Sciences Tools & Services
Index	S&P MIDCAP
Size class	Large

May 15, 2020. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist

Filter Similar Stocks

Similar Top 10

Google: Bio-Rad Laboratories

News	Videos
Wikipedia about Bio-Rad Laboratories	Management
Employee Satisfaction	Customer Satisfaction

Research History: Bio-Rad Laboratories

RESEARCH HISTORY	2017	2018	2019	2020
VALUE
VALUE	35	71	58	56
GROWTH
GROWTH	54	38	53	44
SAFETY
SAFETY	42	94	94	78
COMBINED
COMBINED	50	88	82	67

Last update of Combined Rank: 15-May-2020. Financial reporting date used for calculating ranks: 31-Mar-2020. Stock research history is based on the Obermatt Method. The higher the rank, the better Bio-Rad Laboratories is in the corresponding investment strategy.

Value Metrics in Detail

VALUE METRICS	2017	2018	2019	2020
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S)	64	59	42	46
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E)	34	100	98	96
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book)	61	62	56	52
DIVIDEND YIELD
DIVIDEND YIELD	1	1	1	1
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE	35	71	58	56

Last update of Value Rank: 15-May-2020. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Bio-Rad Laboratories; except for dividend yield where the rank is higher, the higher the yield.

Growth Metrics in Detail

GROWTH METRICS	2017	2018	2019	2020
REVENUE GROWTH
REVENUE GROWTH	36	13	25	19
PROFIT GROWTH
PROFIT GROWTH	55	33	47	59
STOCK RETURNS
STOCK RETURNS	80	86	69	58
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH	54	38	53	44

Last update of Growth Rank: 31-Mar-2020. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Bio-Rad Laboratories.

Safety Metrics in Detail

SAFETY METRICS	2017	2018	2019	2020
LEVERAGE
LEVERAGE	46	56	50	46
REFINANCING
REFINANCING	63	74	62	60
LIQUIDITY
LIQUIDITY	82	81	94	93
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY	42	94	94	78

Last update of Safety Rank: 8-May-2020. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Bio-Rad Laboratories and the more cash is available to service its debt.

Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Bio-Rad Laboratories from May 15, 2020.

We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.